Cargando…
The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success
Japan is a unique country in terms of organ transplantation. Despite the impressive progress in transplant medicine achieved during the late 20th century in many Western countries, Japan was unable to implement a program for organ transplants from brain-dead donors due to persistent public distrust...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586964/ https://www.ncbi.nlm.nih.gov/pubmed/37868876 http://dx.doi.org/10.21037/jtd-22-1861 |
_version_ | 1785123254850027520 |
---|---|
author | Shiraishi, Takeshi Midorikawa, Kensuke Miyahara, So Waseda, Ryuichi Sato, Toshihiko |
author_facet | Shiraishi, Takeshi Midorikawa, Kensuke Miyahara, So Waseda, Ryuichi Sato, Toshihiko |
author_sort | Shiraishi, Takeshi |
collection | PubMed |
description | Japan is a unique country in terms of organ transplantation. Despite the impressive progress in transplant medicine achieved during the late 20th century in many Western countries, Japan was unable to implement a program for organ transplants from brain-dead donors due to persistent public distrust regarding the ethical understanding of “brain death as human death”. In 1997, the Japanese Organ Transplant Law was enacted, and organ transplantation from brain-dead donors was finally legalized. However, this law was strongly opposed by religious leaders, philosophers, politicians, and even medical personnel who did not accept the idea that brain death is human death, so transplant physicians had to start performing transplants in the face of strong social resistance. The Japanese National Lung Transplant System was established based on the following three philosophies: (I) an institutional certification system based on strict standards; (II) a rigorous central monitoring system for transplant results; and (III) a third-party review system to determine eligibility for patient registration. The purpose of these policies was to avoid ethical issues at lung transplant institutes, and to achieve high-quality transplant results. The actual progress of Japanese lung transplantation has been quite unusual compared to other countries. The number of brain-dead organ donations was extremely limited at first, so more than 60% of lung transplants were performed as living-donor transplants during the first 9 years [1998–2006]. The number of brain-dead donations subsequently increased, particularly after the revision of the Organ Transplant Law in 2010 such that the majority of lung transplants are now performed as brain-dead transplantations. Regarding the results of lung transplants, the most recent national registry report indicated that a total of 668 lung transplants including 447 from brain-dead donors and 221 from living donors, had been performed as of 2018. The 5- and 10-year survival rates for brain-dead donor lung transplantation were 71.9% and 57.8%, respectively, with no significant difference between the living-donor and brain-dead-donor groups. These results are comparable with the outcome of preceding programs in the US and European countries. |
format | Online Article Text |
id | pubmed-10586964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-105869642023-10-21 The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success Shiraishi, Takeshi Midorikawa, Kensuke Miyahara, So Waseda, Ryuichi Sato, Toshihiko J Thorac Dis Review Article on Why is the Outcome Good? Secrets of Lung Transplantation in Japan Japan is a unique country in terms of organ transplantation. Despite the impressive progress in transplant medicine achieved during the late 20th century in many Western countries, Japan was unable to implement a program for organ transplants from brain-dead donors due to persistent public distrust regarding the ethical understanding of “brain death as human death”. In 1997, the Japanese Organ Transplant Law was enacted, and organ transplantation from brain-dead donors was finally legalized. However, this law was strongly opposed by religious leaders, philosophers, politicians, and even medical personnel who did not accept the idea that brain death is human death, so transplant physicians had to start performing transplants in the face of strong social resistance. The Japanese National Lung Transplant System was established based on the following three philosophies: (I) an institutional certification system based on strict standards; (II) a rigorous central monitoring system for transplant results; and (III) a third-party review system to determine eligibility for patient registration. The purpose of these policies was to avoid ethical issues at lung transplant institutes, and to achieve high-quality transplant results. The actual progress of Japanese lung transplantation has been quite unusual compared to other countries. The number of brain-dead organ donations was extremely limited at first, so more than 60% of lung transplants were performed as living-donor transplants during the first 9 years [1998–2006]. The number of brain-dead donations subsequently increased, particularly after the revision of the Organ Transplant Law in 2010 such that the majority of lung transplants are now performed as brain-dead transplantations. Regarding the results of lung transplants, the most recent national registry report indicated that a total of 668 lung transplants including 447 from brain-dead donors and 221 from living donors, had been performed as of 2018. The 5- and 10-year survival rates for brain-dead donor lung transplantation were 71.9% and 57.8%, respectively, with no significant difference between the living-donor and brain-dead-donor groups. These results are comparable with the outcome of preceding programs in the US and European countries. AME Publishing Company 2023-08-17 2023-09-28 /pmc/articles/PMC10586964/ /pubmed/37868876 http://dx.doi.org/10.21037/jtd-22-1861 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Review Article on Why is the Outcome Good? Secrets of Lung Transplantation in Japan Shiraishi, Takeshi Midorikawa, Kensuke Miyahara, So Waseda, Ryuichi Sato, Toshihiko The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success |
title | The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success |
title_full | The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success |
title_fullStr | The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success |
title_full_unstemmed | The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success |
title_short | The history of Japanese lung transplantation: the unique pathway to establishing the program and its initial success |
title_sort | history of japanese lung transplantation: the unique pathway to establishing the program and its initial success |
topic | Review Article on Why is the Outcome Good? Secrets of Lung Transplantation in Japan |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586964/ https://www.ncbi.nlm.nih.gov/pubmed/37868876 http://dx.doi.org/10.21037/jtd-22-1861 |
work_keys_str_mv | AT shiraishitakeshi thehistoryofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT midorikawakensuke thehistoryofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT miyaharaso thehistoryofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT wasedaryuichi thehistoryofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT satotoshihiko thehistoryofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT shiraishitakeshi historyofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT midorikawakensuke historyofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT miyaharaso historyofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT wasedaryuichi historyofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess AT satotoshihiko historyofjapaneselungtransplantationtheuniquepathwaytoestablishingtheprogramanditsinitialsuccess |